PPIDT00029

Drug Information
NameTenecteplase
SequenceSYQVICRDEKTQMIYQQHQSWLRPVLRSNRVEYCWCNSGRAQCHSVPVKSCSEPRCFNGGTCQQALYFSDFVCQCPEGFAGKCCEIDTRATCYEDQGISYRGNWSTAESGAECTNWQSSALAQKPYSGRRPDAIRLGLGNHNYCRNPDRDSKPWCYVFKAGKYSSEFCSTPACSEGNSDCYFGNGSAYRGTHSLTESGASCLPWNSMILIGKVYTAQNPSAQALGLGKHNYCRNPDGDAKPWCHVLKNRRLTWEYCDVPSCSTCGLRQYSQPQFRIKGGLFADIASHPWQAAIFAAAAASPGERFLCGGILISSCWILSAAHCFQERFPPHHLTVILGRTYRVVPGEEEQKFEVEKYIVHKEFDDDTYDNDIALLQLKSDSSRCAQESSVVRTVCLPPADLQLPDWTECELSGYGKHEALSPFYSERLKEAHVRLYPSSRCTSQHLLNRTVTDNMLCAGDTRSGGPQANLHDACQGDSGGPLVCLNDGRMTLVGIISWGLGCGQKDVPGVYTKVTNYLDWIRDNMRP
DrugBank_IDDB00031
Typebiotech
IndicationFor treatment of myocardial infarction and lysis of intracoronary emboli

Dosage Forms
Form Route Strength
Injection, powder, for solution —
10000 IU
Injection, powder, for solution Intravenous
10000 units
Injection, powder, for solution Intravenous
5000 units
Injection, powder, for solution Intravenous
8000 units
Injection, powder, for solution Intravenous; Parenteral
10000 U/10ML
Injection, powder, for solution Intravenous; Parenteral
6000 U/6ML
Injection, powder, for solution Intravenous; Parenteral
8000 U/8ML
Powder Intravenous
10000 U/10ML
Powder Intravenous
6000 U/6ML
Powder Intravenous
8000 U/8ML
Solution Intravenous
30.000 mg
Injection, powder, for solution —
5 mg/mL
Injection, powder, for solution Intravenous bolus
50 mg
Injection, powder, for solution Parenteral
3000000 mg
Injection, powder, lyophilized, for solution Parenteral
4000000 mg
Injection, powder, for solution Intravenous
10000 u
Injection, powder, lyophilized, for solution Intravenous
5000000 mg
Injection, powder, for solution Intravenous
Powder Intravenous
Injection, powder, lyophilized, for solution; kit Intravenous
52.5 mg/50mg
Kit Intravenous; Topical
Powder, for solution Intravenous
50 mg / vial
Powder Intravenous
40 mg/1vial
Target Information
Role Uniprot_ID Gene_Name Entity_Name Organism Actions Internal link
target P00747 PLG Plasminogen Homo sapiens activator Link